Pathology Resident Wiki
No edit summary
Line 1: Line 1:
 
[[File:Placeholder|right|300px]]
 
[[File:Placeholder|right|300px]]
   
  +
[[File:Template_Placeholder|right|300px]]
 
   
   
Line 16: Line 16:
   
 
==Expression in Neoplastic Entities==
 
==Expression in Neoplastic Entities==
=====Benign=====
+
====='''<u>Benign</u>'''=====
  +
{| border="1" cellpadding="1" cellspacing="1" style="width: 500px; "
  +
|Tumor name
  +
|% Positive Staining
  +
|Number of Cases
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|}
  +
  +
  +
====='''<u>Intermediate/Uncertain Malignant Potential</u>'''=====
  +
{| border="1" cellpadding="1" cellspacing="1" style="width: 500px; "
  +
|Tumor name
  +
|% Positive Staining
  +
|Number of Cases
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|}
   
   
=====Intermediate=====
+
====='''<u>Malignant</u>'''=====
  +
{| border="1" cellpadding="1" cellspacing="1" style="width: 500px; "
  +
|Tumor name
  +
|% Positive Staining
  +
|Number of Cases
  +
|-
  +
|
  +
|
  +
|
  +
|-
 
|Salivary duct carcinoma (AR+ in more than 90%)<ref>[http://www.ncbi.nlm.nih.gov/pubmed/10757407 Am J Surg Pathol. 2000 Apr;24(4):579-86.]</ref>
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|-
  +
|
  +
|
  +
|
  +
|}
   
  +
Salivary duct carcinoma (AR+ in more than 90%)<ref>[http://www.ncbi.nlm.nih.gov/pubmed/10757407 Am J Surg Pathol. 2000 Apr;24(4):579-86.]</ref>
=====Malignant=====
 
*Salivary duct carcinoma (AR+ in more than 90%)<ref>[http://www.ncbi.nlm.nih.gov/pubmed/10757407 Am J Surg Pathol. 2000 Apr;24(4):579-86.]</ref>
 
   
 
==Expression in Non-Neoplastic Entities==
 
==Expression in Non-Neoplastic Entities==

Revision as of 15:40, 3 February 2011



Synonyms

Antibodies

Technical Info

Staining Pattern

  • Nuclear (like all hormone receptor immunostains)

Expression in Normal Tissues

Expression in Neoplastic Entities

Benign
Tumor name % Positive Staining Number of Cases


Intermediate/Uncertain Malignant Potential
Tumor name % Positive Staining Number of Cases


Malignant
Tumor name % Positive Staining Number of Cases
Salivary duct carcinoma (AR+ in more than 90%)[1]

Salivary duct carcinoma (AR+ in more than 90%)[2]

Expression in Non-Neoplastic Entities

Practical Uses / Panels

Common Pitfalls

References